[{"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-001", "question": "A 3-week-old male infant presents with progressive jaundice, acholic stools, and hepatomegaly. Laboratory studies reveal total bilirubin 12.4 mg/dL (direct 9.8 mg/dL), GGT 890 U/L, and ALT 156 U/L. Abdominal ultrasound shows absence of the gallbladder and a triangular cord sign at the porta hepatis. HIDA scan demonstrates good hepatic uptake but no intestinal excretion at 24 hours. Intraoperative cholangiogram confirms biliary atresia. The Kasai portoenterostomy is performed at 28 days of life. Which of the following findings at the time of surgery most strongly predicts failure to achieve bile drainage and need for liver transplantation within 2 years?", "options": ["Presence of bile duct remnants less than 150 micrometers in diameter at the porta hepatis", "Bridging fibrosis on liver biopsy without established cirrhosis", "Cytomegalovirus IgM positivity in the infant", "Splenic malformation syndrome with polysplenia", "Absence of the common bile duct with patent proximal hepatic ducts"], "answer": "A", "answer_index": 0, "explanation": "The diameter of bile duct remnants at the porta hepatis is the strongest histopathologic predictor of successful bile drainage after Kasai portoenterostomy. Remnants less than 150 micrometers are associated with poor outcomes and early transplant need. Bridging fibrosis without cirrhosis does not preclude successful drainage. CMV-associated biliary atresia and splenic malformation syndrome have variable outcomes but are not as predictive as duct remnant size. Absence of common bile duct with patent proximal ducts actually suggests a more favorable anatomy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "A", "model_outputs": "NOT FOR CLINICAL USE.\n\nThe question asks for the strongest predictor of failure to achieve bile drainage and subsequent need for liver transplantation within 2 years following a Kasai portoenterostomy for biliary atresia. The Kasai procedure involves connecting the jejunum to the fibrous cord at the porta hepatis, aiming to bypass the atretic extrahepatic bile ducts and allow bile to drain.\n\nLet's analyze the options:\nA. Presence of bile duct remnants less than 150 micrometers in diameter at the porta hepatis: The success of the Kasai portoenterostomy relies on the presence of patent bile ductules within the fibrotic cord at the porta hepatis. If these remnants are very small (<150 micrometers), it implies a lack of functioning bile channels that can be connected to the intestine, thus predicting failure to achieve bile drainage. This is a well-established indicator of poor prognosis for the Kasai procedure.\n\nB. Bridging fibrosis on liver biopsy without established cirrhosis: Bridging fibrosis indicates significant liver damage but not yet end-stage cirrhosis. While the presence of fibrosis is a negative prognostic factor for long-term outcomes, it is a consequence of cholestasis. The primary factor determining the success of the Kasai procedure is the ability to establish bile drainage. If drainage is successful, fibrosis might improve. If drainage fails, fibrosis will progress. Therefore, the state of the porta hepatis structures is a more direct predictor of initial drainage failure.\n\nC. Cytomegalovirus IgM positivity in the infant: Cytomegalovirus infection can cause neonatal cholestasis, but it is an infectious cause rather than a direct predictor of the surgical success of the Kasai procedure for intrinsic biliary atresia.\n\nD. Splenic malformation syndrome with polysplenia: While these syndromes can be associated with biliary atresia, polysplenia itself is not considered a primary predictor of the success of the Kasai portoenterostomy in restoring bile flow.\n\nE. Absence of the common bile duct with patent proximal hepatic ducts: Biliary atresia is characterized by the absence or atresia of the extrahepatic bile ducts. The critical factor is whether the intrahepatic ducts are patent. The presence of patent proximal hepatic ducts is actually a favorable sign for the Kasai procedure, suggesting that there are channels to connect, not a predictor of failure.\n\nOption A directly addresses the anatomical integrity of the terminal bile duct structures at the porta hepatis, which is crucial for the technical success of the Kasai procedure in establishing bile drainage. A very small diameter of these remnants strongly suggests the absence or severe underdevelopment of patent ductules.\n\nThe final answer is $\\boxed{A}$."}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-002", "question": "A 34-year-old woman is brought to the emergency department after a house fire. She was found unconscious in a closed room. On arrival, she is obtunded with GCS 8. Vital signs: BP 142/88 mmHg, HR 118 bpm, RR 28/min, SpO2 98% on 100% FiO2 via non-rebreather mask. Physical examination reveals cherry-red skin coloration, no visible burns, and no soot in the oropharynx. Arterial blood gas on 100% oxygen shows pH 7.18, PaCO2 28 mmHg, PaO2 487 mmHg, lactate 14 mmol/L. Carboxyhemoglobin level is 8%. Co-oximetry reveals an additional abnormal hemoglobin species at 18%. Which of the following is the most appropriate next step in management?", "options": ["Emergent hyperbaric oxygen therapy", "Intravenous hydroxocobalamin 5 grams", "Methylene blue 1-2 mg/kg intravenously", "Exchange transfusion", "Sodium thiosulfate 12.5 grams intravenously"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation with severe lactic acidosis, obtundation, relatively low carboxyhemoglobin but an additional abnormal hemoglobin species (18% methemoglobin-like reading which actually represents cyanohemoglobin on co-oximetry) in a fire victim strongly suggests cyanide toxicity from combustion of synthetic materials. Hydroxocobalamin is the first-line antidote for cyanide poisoning as it directly binds cyanide to form cyanocobalamin. Hyperbaric oxygen addresses CO toxicity but CO level is only 8%. Methylene blue treats methemoglobinemia but is contraindicated with cyanide. Sodium thiosulfate is slower acting and used as adjunct therapy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "target_topic", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "B", "model_outputs": "The patient presents with severe symptoms following smoke inhalation from a house fire, including obtundation (GCS 8), severe metabolic acidosis (pH 7.18), and markedly elevated lactate (14 mmol/L). While the carboxyhemoglobin (COHb) level is 8%, which is mildly elevated, these symptoms are disproportionately severe for this level of CO exposure alone. The presence of cherry-red skin coloration is noted, which can be seen in both carbon monoxide and cyanide poisoning.\n\nCrucially, the co-oximetry reveals \"an additional abnormal hemoglobin species at 18%.\" This finding is significant. If this abnormal hemoglobin is not COHb or methemoglobin (MetHb), it points towards another toxic insult. In the context of fire exposure, which can release hydrogen cyanide (HCN) from burning plastics, wool, and silk, cyanide poisoning is a major concern. Cyanide binds to cytochrome c oxidase, inhibiting cellular respiration and leading to profound cellular hypoxia and lactic acidosis, consistent with the patient's presentation. Cyanogen can bind to hemoglobin, forming cyanhemoglobin (CyHb), which could potentially be detected as an abnormal hemoglobin species by some co-oximeters.\n\nLet's evaluate the options:\nA. Emergent hyperbaric oxygen therapy (HBO): HBO is the definitive treatment for severe carbon monoxide poisoning, accelerating the release of CO from hemoglobin and improving oxygen delivery. However, it is not the primary treatment for cyanide poisoning. While CO poisoning is present (COHb 8%), the severity of the patient's condition suggests an additional or more significant toxin.\n\nB. Intravenous hydroxocobalamin 5 grams: Hydroxocobalamin is a direct-acting antidote for cyanide poisoning. It rapidly binds to cyanide ions to form cyanocobalamin (vitamin B12a), which is non-toxic and excreted in the urine. It is highly effective and considered the first-line treatment for significant cyanide poisoning. Given the clinical picture suggestive of cyanide poisoning (severe acidosis, high lactate, symptoms disproportionate to COHb level, plus the \"additional abnormal hemoglobin species\" potentially being cyanhemoglobin), hydroxocobalamin is a strong candidate.\n\nC. Methylene blue 1-2 mg/kg intravenously: Methylene blue is used to treat methemoglobinemia. If the \"additional abnormal hemoglobin species\" was methemoglobin and significant, this would be considered. However, there is no explicit mention of methemoglobinemia, and methylene blue is contraindicated in co-ingestion of cyanide, as it can worsen methemoglobinemia and potentially exacerbate cyanide toxicity by competing for sulfation pathways.\n\nD. Exchange transfusion: This is a treatment for conditions like severe neonatal jaundice or certain hemolytic anemias and is not indicated for toxicological exposures like CO or cyanide poisoning.\n\nE. Sodium thiosulfate 12.5 grams intravenously: Sodium thiosulfate is also an antidote for cyanide poisoning, acting as a sulfur donor to convert cyanide to thiocyanate. However, hydroxocobalamin has largely replaced sodium thiosulfate/sodium nitrite kits due to its faster onset, greater efficacy, and better safety profile (avoiding the adverse effects of nitrites, such as methemoglobinemia and hypotension).\n\nConsidering the strong suspicion for cyanide poisoning, possibly co-existing with carbon monoxide poisoning, due to the severity of metabolic acidosis, high lactate, and the presence of an \"additional abnormal hemoglobin species\" in a fire victim, hydroxocobalamin is the most appropriate immediate next step to directly counteract the cyanide toxicity. This would address the cellular hypoxia mechanism.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-003", "question": "A 28-year-old woman at 32 weeks gestation presents with sudden onset severe headache, visual disturbances, and confusion. Blood pressure is 178/112 mmHg. Laboratory studies show platelets 68,000/μL, LDH 890 U/L, AST 245 U/L, creatinine 1.8 mg/dL, and peripheral smear with schistocytes. She receives magnesium sulfate and labetalol. Emergent cesarean delivery is performed. Postpartum day 3, despite delivery, her platelet count drops to 42,000/μL, creatinine rises to 2.9 mg/dL, and she develops new neurological symptoms. ADAMTS13 activity returns at 58%. Which additional finding would most strongly support initiating eculizumab therapy?", "options": ["Positive direct antiglobulin test", "Complement factor H mutation on genetic testing", "Elevated soluble fms-like tyrosine kinase-1 levels", "Low C3 with normal C4 levels", "Presence of anti-phospholipid antibodies"], "answer": "B", "answer_index": 1, "explanation": "This presentation of postpartum thrombotic microangiopathy not resolving after delivery with ADAMTS13 >10% suggests complement-mediated TMA (atypical HUS) rather than TTP or HELLP syndrome. Complement factor H mutation confirms complement dysregulation and strongly supports eculizumab (C5 inhibitor) therapy. Low C3 with normal C4 suggests alternative pathway activation but is nonspecific. Elevated sFlt-1 would suggest ongoing preeclampsia-related pathology. Positive DAT would suggest Evans syndrome, and anti-phospholipid antibodies suggest catastrophic APS, both requiring different management.", "generator_model": "claude-opus-4-5-20251101", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "topics_mapped", "source_label_raw": "obstetrics", "source_quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed124", "source_question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed124-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251129T135352000Z_claude-opus-4-5-20251101_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251129T135352000Z_claude-opus-4-5-20251101_seed124.jsonl", "pred": "B", "model_outputs": "The patient presents with a severe thrombotic microangiopathy (TMA) characterized by thrombocytopenia, microangiopathic hemolytic anemia (schistocytes, elevated LDH), and organ damage (elevated creatinine, neurological symptoms) which is worsening postpartum despite delivery. The normal ADAMTS13 activity (58%) rules out typical thrombotic thrombocytopenic purpura (TTP). The clinical picture, especially the worsening TMA and organ damage, in the context of recent pregnancy and delivery, raises suspicion for atypical hemolytic uremic syndrome (aHUS). Eculizumab is a potent inhibitor of the terminal complement pathway and is a standard therapy for aHUS.\n\nWe are looking for a finding that would most strongly support initiating eculizumab therapy. Eculizumab is used to treat complement-mediated disorders, most commonly aHUS, which results from uncontrolled activation of the alternative complement pathway.\n\nLet's analyze the options:\nA. Positive direct antiglobulin test (DAT): Indicates autoimmune hemolytic anemia, which is a different mechanism from TMA and not an indication for eculizumab.\nB. Complement factor H mutation on genetic testing: Factor H is a crucial regulator of the alternative complement pathway. Mutations in the *CFH* gene are among the most common causes of inherited aHUS. Identifying such a mutation strongly supports a diagnosis of aHUS, which is the primary indication for eculizumab.\nC. Elevated soluble fms-like tyrosine kinase-1 (sFlt-1) levels: sFlt-1 is associated with endothelial dysfunction in preeclampsia and HELLP syndrome. While relevant to the initial presentation, it does not directly support the use of eculizumab, as this is a marker of the underlying condition leading to preeclampsia, not necessarily a persistent complement-mediated TMA requiring eculizumab.\nD. Low C3 with normal C4 levels: Low C3 and normal C4 indicate activation of the alternative complement pathway, while the classical and lectin pathways are relatively spared. This is highly suggestive of aHUS. This finding strongly supports considering eculizumab.\nE. Presence of anti-phospholipid antibodies: Antiphospholipid antibody syndrome can cause thrombotic events but is not typically treated with eculizumab.\n\nComparing options B and D, both point towards complement dysregulation and aHUS. However, a confirmed genetic mutation in a complement regulatory protein (like Factor H) provides a more definitive etiological diagnosis for aHUS. While low C3 is a marker of complement pathway activation, genetic testing identifies the underlying defect that predisposes to this activation and identifies a specific subset of aHUS for which eculizumab is indicated. In many clinical scenarios, a confirmed genetic mutation in a complement regulatory gene is considered the gold standard for diagnosing inherited aHUS and provides the strongest rationale for initiating long-term therapy like eculizumab, especially when the clinical picture is consistent with TMA. Given the worsening of symptoms postpartum, suggesting an underlying condition not resolved by delivery, identifying a genetic predisposition is very strong supporting evidence.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-004", "question": "A 58-year-old man with a history of chronic alcohol use disorder is undergoing emergency laparotomy for perforated duodenal ulcer. He received 4 units of packed red blood cells and 2 units of fresh frozen plasma intraoperatively. Thirty minutes after induction with propofol, fentanyl, and rocuronium, the anesthesiologist notes progressive hypotension (MAP 52 mmHg), tachycardia (128 bpm), elevated peak airway pressures (42 cmH2O), and oxygen desaturation to 88%. Central venous pressure has increased from 6 to 18 mmHg. There is no urticaria or angioedema. Bronchospasm is noted on auscultation. Serum tryptase drawn at this time returns elevated at 48 ng/mL (normal <11.4). Which of the following mechanisms most likely explains this patient's reaction?", "options": ["IgE-mediated mast cell degranulation to latex proteins", "Complement activation by anti-IgA antibodies", "Direct mast cell activation by neuromuscular blocking agent", "Bradykinin accumulation from C1-esterase inhibitor deficiency", "Transfusion-related acute lung injury from donor anti-HLA antibodies"], "answer": "C", "answer_index": 2, "explanation": "Neuromuscular blocking agents, particularly rocuronium, are the most common cause of perioperative anaphylaxis. They can cause direct (non-IgE mediated) mast cell degranulation through MRGPRX2 receptor activation, which explains the elevated tryptase, bronchospasm, and cardiovascular collapse without prior sensitization. IgA deficiency reactions typically present with urticaria and occur during transfusion. TRALI causes non-cardiogenic pulmonary edema without elevated tryptase or bronchospasm. Bradykinin-mediated angioedema does not cause bronchospasm or elevated tryptase. Latex allergy is less common and typically requires mucosal contact.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "abms_specialty": "Anesthesiology", "abms_source": "target_topic", "source_label_raw": "Anesthesiology", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "C", "model_outputs": "The patient presents with a constellation of symptoms highly suggestive of anaphylaxis or an anaphylactoid reaction, occurring shortly after the administration of induction agents, including rocuronium. The key findings are:\n1.  Hypotension (MAP 52 mmHg), tachycardia (128 bpm): Characteristic of distributive shock seen in anaphylaxis.\n2.  Elevated peak airway pressures (42 cmH2O) and oxygen desaturation to 88%: Indicate significant airway obstruction and/or pulmonary dysfunction.\n3.  Bronchospasm on auscultation: A direct sign of airway narrowing, common in anaphylaxis.\n4.  Increased Central Venous Pressure (CVP) from 6 to 18 mmHg: This can occur due to increased pulmonary vascular resistance from bronchospasm, vasodilation with impaired venous return, or myocardial dysfunction.\n5.  Elevated serum tryptase (48 ng/mL): This is a specific marker for mast cell degranulation and is elevated in anaphylaxis and anaphylactoid reactions.\n6.  Absence of urticaria or angioedema: While common in IgE-mediated anaphylaxis, their absence does not rule out anaphylaxis, especially anaphylactoid reactions.\n\nLet's analyze the options:\n\nA.  IgE-mediated mast cell degranulation to latex proteins: While latex can cause anaphylaxis, the vignette does not mention any exposure to latex products around the time of the reaction. Furthermore, latex reactions often involve urticaria and angioedema, which are explicitly absent in this patient.\n\nB.  Complement activation by anti-IgA antibodies: Patients with IgA deficiency can develop antibodies to IgA. Transfusion of blood products containing IgA can trigger a severe anaphylactic reaction mediated by complement activation. This can lead to hypotension, bronchospasm, and elevated tryptase. This is a plausible cause, especially given the transfusions. However, it is statistically less common than anaphylactoid reactions to anesthetic agents.\n\nC.  Direct mast cell activation by neuromuscular blocking agent: Neuromuscular blocking agents (NMBAs), particularly rocuronium, succinylcholine, and atracurium, are well-known causes of anaphylactoid reactions. These reactions are not IgE-mediated but involve direct activation of mast cells, leading to the release of mediators like histamine. Symptoms are similar to IgE-mediated anaphylaxis, including hypotension, bronchospasm, and respiratory distress, with elevated tryptase. The timing (after induction with rocuronium) and the absence of urticarial/angioedematous features make this a very strong possibility and one of the most common causes of intraoperative anaphylaxis.\n\nD.  Bradykinin accumulation from C1-esterase inhibitor deficiency: This mechanism is characteristic of hereditary or acquired angioedema. While it can cause hypotension and airway swelling, it typically presents with angioedema (swelling of lips, tongue, face, larynx, or gastrointestinal tract) and does not lead to elevated serum tryptase levels. The patient has no urticaria or angioedema.\n\nE.  Transfusion-related acute lung injury (TRALI) from donor anti-HLA antibodies: TRALI is a form of non-cardiogenic pulmonary edema that occurs after transfusion. It presents with hypoxemia, dyspnea, and pulmonary infiltrates. While hypotension can occur, elevated serum tryptase is not a feature of TRALI. The prominent bronchospasm and elevated tryptase strongly point away from TRALI being the primary mechanism.\n\nComparing options B and C, the immediate timing after induction with rocuronium and the typical presentation of anaphylactoid reactions to NMBAs (including bronchospasm and lack of dermal manifestations as prominently) make option C the most likely explanation. Anaphylactoid reactions to NMBAs are common intraoperative emergencies.\n\nThe final answer is $\\boxed{C}$."}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-005", "question": "A 28-year-old woman with treatment-resistant schizophrenia has been on clozapine 450 mg daily for 8 months with good symptom control. She presents with fever (39.2°C), sore throat, and malaise for 2 days. Laboratory studies reveal WBC 1,200/μL with absolute neutrophil count (ANC) 180/μL, hemoglobin 11.2 g/dL, and platelets 198,000/μL. Clozapine is immediately discontinued. After 14 days of supportive care including G-CSF, her ANC recovers to 2,400/μL. Given her excellent prior response to clozapine, the treatment team considers rechallenge. Which of the following factors most strongly contraindicates clozapine rechallenge in this patient?", "options": ["ANC nadir below 500/μL during the index episode", "Duration of neutropenia exceeding 10 days", "Concurrent use of G-CSF during recovery", "Time to ANC recovery exceeding 21 days from clozapine discontinuation", "Presence of fever during the neutropenic episode"], "answer": "A", "answer_index": 0, "explanation": "An ANC nadir below 500/μL (severe neutropenia/agranulocytosis) during clozapine-induced neutropenia is an absolute contraindication to rechallenge according to FDA guidelines and the Clozapine REMS program. Patients with ANC that dropped below 500/μL have a significantly higher risk of recurrent severe neutropenia with rechallenge. Duration of neutropenia, G-CSF use, recovery time, and presence of fever are concerning but do not absolutely contraindicate rechallenge if the nadir remained above 500/μL. The severity of the nadir is the critical determinant.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "A", "model_outputs": "The question asks to identify the factor that *most strongly* contraindicates clozapine rechallenge in a patient who experienced neutropenia while on clozapine. Let's analyze the options based on clozapine monitoring guidelines.\n\nThe patient presented with fever, sore throat, malaise, leukopenia (WBC 1,200/μL), and severe neutropenia (absolute neutrophil count [ANC] 180/μL). Clozapine was discontinued, and her ANC recovered to 2,400/μL after 14 days with supportive care and G-CSF.\n\nWe need to evaluate each option in the context of contraindications for clozapine rechallenge:\n\nA. ANC nadir below 500/μL during the index episode: The patient's ANC nadir was 180/μL, which is well below 500/μL. This level is classified as Grade 4 neutropenia and is widely considered a significant risk factor. Many clozapine monitoring guidelines state that if the ANC falls below 500/μL, clozapine should be discontinued, and rechallenge is generally considered contraindicated or not recommended.\n\nB. Duration of neutropenia exceeding 10 days: The patient's ANC recovered after 14 days. This means neutropenia (which is defined as ANC < 1500/μL, and in this case was severe) persisted for at least 14 days. Prolonged neutropenia is a concern, but its contraindicatory strength might be lesser than an extremely low nadir or the presence of fever.\n\nC. Concurrent use of G-CSF during recovery: Granulocyte colony-stimulating factor (G-CSF) is a treatment used to accelerate neutrophil recovery. Its use does not contraindicate rechallenge; rather, it signifies the severity of the neutropenia necessitating aggressive intervention.\n\nD. Time to ANC recovery exceeding 21 days from clozapine discontinuation: This option is factually incorrect as the patient's ANC recovered within 14 days.\n\nE. Presence of fever during the neutropenic episode: The patient had a fever of 39.2°C along with neutropenia. Fever in the context of neutropenia is a serious sign, indicating a high risk of potentially life-threatening infection. Guidelines often state that neutropenia accompanied by fever warrants immediate discontinuation of clozapine and makes rechallenge strongly discouraged.\n\nComparing options A and E, both represent critical reasons for concern regarding rechallenge. However, guidelines often use stronger terminology for the ANC nadir falling below 500/μL. For example, the FDA's Clozapine REMS guidance generally states that rechallenge is not recommended if clozapine is discontinued due to grade 3 or 4 neutropenia (ANC < 1000/mm³ or < 500/mm³, respectively), or neutropenia associated with fever or signs of infection. Some specific guidelines classify ANC < 500/μL as a contraindication, while fever with neutropenia might be termed \"strongly discouraged\" or \"generally not recommended.\" The term \"contraindicated\" implies a stronger prohibition than \"strongly discouraged.\" Given that the patient's ANC nadir was 180/μL, this falls into the category of severe neutropenia that is most consistently cited as a contraindication for rechallenge.\n\nThe final answer is $\\boxed{A}$."}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-006", "question": "A 67-year-old man undergoes elective right hemicolectomy for a cecal adenocarcinoma. On postoperative day 3, he develops fever (38.9°C), tachycardia, and diffuse abdominal tenderness with guarding. CT scan reveals free air, a 4-cm fluid collection near the ileocolic anastomosis, and no contrast extravasation on oral contrast study. Laboratory studies show WBC 18,400/μL and lactate 3.2 mmol/L. At re-exploration, the anastomosis appears intact but edematous with surrounding fibrinous exudate. There is 400 mL of turbid fluid in the peritoneal cavity. Gram stain of the fluid shows gram-negative rods and gram-positive cocci in chains. Which of the following is the most appropriate surgical management?", "options": ["Washout with drain placement and preservation of anastomosis", "Takedown of anastomosis with end ileostomy and mucous fistula", "Takedown of anastomosis with end ileostomy and Hartmann's pouch", "Resection of anastomosis with primary re-anastomosis and proximal diverting loop ileostomy", "Washout with omental patch reinforcement of anastomosis"], "answer": "B", "answer_index": 1, "explanation": "This patient has an anastomotic leak with peritonitis despite the anastomosis appearing grossly intact (contained leak with surrounding contamination). In the setting of generalized peritonitis, hemodynamic compromise (tachycardia, elevated lactate), and polymicrobial contamination, the safest approach is takedown of the anastomosis with end ileostomy and mucous fistula. This is preferred over Hartmann's pouch because the distal bowel (ascending/transverse colon) is healthy and can be exteriorized. Preserving the anastomosis or performing primary re-anastomosis in this contaminated, inflamed field carries unacceptable leak risk.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "abms_specialty": "General Surgery", "abms_source": "target_topic", "source_label_raw": "General Surgery", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "B", "model_outputs": "The patient presents with signs and symptoms highly suggestive of an anastomotic leak on postoperative day 3, including fever, tachycardia, diffuse abdominal tenderness with guarding, leukocytosis, elevated lactate, free air on CT, and turbid fluid in the peritoneal cavity. At re-exploration, the anastomosis is described as intact but edematous with surrounding fibrinous exudate, and there is significant turbid fluid contamination of the peritoneum. This indicates a significant issue with the anastomosis, leading to spillage and peritonitis.\n\nSurgical management must address source control and prevent further contamination.\n- Options A and E (preservation or reinforcement of anastomosis) are inappropriate given the evidence of peritonitis and significant contamination with free air and turbid fluid.\n- Option D (re-section with primary re-anastomosis and diverting loop ileostomy) is generally too aggressive for an acutely septic patient with an inflamed anastomosis and contaminated peritoneal cavity. Re-doing an anastomosis in such a setting carries a high risk of failure.\n- Options B and C involve taking down the anastomosis and diverting the fecal stream. This is appropriate management for a significant anastomotic leak with peritonitis. The difference lies in the management of the distal bowel segment after the takedown.\n\nOption B: Takedown of anastomosis with end ileostomy and mucous fistula. This involves creating an ileostomy to divert fecal contents and bringing the stapled end of the colon to the skin as a mucous fistula. This allows for drainage and monitoring of the distal bowel, and is a common approach when the distal segment is healthy and there is a plan for potential future reconstruction.\n\nOption C: Takedown of anastomosis with end ileostomy and Hartmann's pouch. This involves an end ileostomy and oversewing the distal end of the colon, leaving it in the abdominal cavity. This is akin to a Hartmann's procedure, typically reserved for cases with severe contamination of the distal segment or when future re-anastomosis is not intended or considered technically difficult. However, \"Hartmann's pouch\" typically refers to the rectal stump. For a colonic stump after an ileocolic anastomosis, exteriorizing it as a mucous fistula is often preferred if the colon is healthy.\n\nGiven the description of the anastomosis as \"intact but edematous with surrounding fibrinous exudate,\" and no specific mention of severe disease or extensive contamination of the distal colon itself, bringing the distal colonic end out as a mucous fistula (Option B) is a standard and appropriate management strategy. It provides secure diversion and allows for easier management and potential future reversal compared to oversewing a potentially compromised or contaminated colonic stump.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-007", "question": "A 58-year-old man with type 2 diabetes presents with sudden painless vision loss in his right eye upon awakening. Best-corrected visual acuity is 20/200 OD and 20/25 OS. Funduscopic examination of the right eye reveals diffuse retinal whitening with a cherry-red spot at the macula, attenuated arterioles, and segmentation of blood columns (\"boxcarring\"). Intraocular pressure is 14 mmHg OD and 15 mmHg OS. Carotid duplex shows 40% stenosis of the right internal carotid artery. Echocardiogram reveals no intracardiac thrombus. The patient presents 3 hours after symptom onset. Which of the following interventions has the strongest evidence for visual recovery in this condition?", "options": ["Anterior chamber paracentesis to lower intraocular pressure", "Intravenous tissue plasminogen activator", "Hyperbaric oxygen therapy", "Intra-arterial thrombolysis via ophthalmic artery catheterization", "Conservative management with secondary stroke prevention"], "answer": "E", "answer_index": 4, "explanation": "This patient has central retinal artery occlusion (CRAO). Despite numerous proposed interventions including ocular massage, anterior chamber paracentesis, carbogen inhalation, IV or intra-arterial thrombolysis, and hyperbaric oxygen, no treatment has demonstrated consistent efficacy in randomized controlled trials for improving visual outcomes in CRAO. The EAGLE study found no benefit of intra-arterial thrombolysis. Current evidence supports conservative management with urgent evaluation and treatment for stroke risk factors, as CRAO is considered a stroke equivalent. Secondary prevention with antiplatelet therapy and risk factor modification is the evidence-based approach.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "abms_specialty": "Ophthalmology", "abms_source": "target_topic", "source_label_raw": "Ophthalmology", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed128.jsonl", "pred": "D", "model_outputs": "The patient presents with classic signs and symptoms of a central retinal artery occlusion (CRAO): sudden, painless vision loss, retinal whitening, a cherry-red spot at the macula, attenuated arterioles, and segmented blood columns. The onset was 3 hours prior to presentation, which is within the critical time window for potential intervention to restore vision.\n\nLet's evaluate the options based on their evidence for visual recovery in CRAO:\n\nA.  Anterior chamber paracentesis: This procedure is aimed at lowering intraocular pressure (IOP). While elevated IOP can exacerbate retinal ischemia, the patient's IOP is normal (14 mmHg OD). Therefore, paracentesis is unlikely to be beneficial and has no strong evidence for restoring vision in CRAO.\n\nB.  Intravenous tissue plasminogen activator (IV tPA): IV tPA is the standard treatment for acute ischemic stroke. While it can potentially reperfuse cranial arteries, its use in isolated CRAO is controversial. Studies suggest a modest benefit, but it carries significant risks of systemic hemorrhage with uncertain efficacy for direct retinal reperfusion compared to more targeted approaches. Guidelines generally do not recommend it for isolated CRAO unless it's part of a larger stroke.\n\nC.  Hyperbaric oxygen therapy (HBOT): HBOT aims to increase retinal oxygen supply and can help reduce ischemia-induced edema. It may preserve retinal function for a longer period, potentially allowing for recovery if reperfusion can be achieved later. However, the evidence for significant *visual recovery* from HBOT in acute CRAO is not as strong as for reperfusion therapies.\n\nD.  Intra-arterial thrombolysis via ophthalmic artery catheterization: This technique involves directly delivering a thrombolytic agent to the occluded ophthalmic artery. Studies and case series have shown that this method can restore blood flow to the retina and lead to visual recovery in a significant percentage of patients, particularly when administered within the first few hours (typically up to 6-12 hours, with earlier intervention yielding better results). Given the patient's presentation within 3 hours, this approach offers the most direct and potent means of attempting to dissolve the clot and restore perfusion, with the strongest supporting evidence for visual recovery in this specific acute setting among the options provided.\n\nE.  Conservative management with secondary stroke prevention: This involves measures like aspirin, statins, diabetes control, and managing hypertension. While crucial for preventing future vascular events, these measures do not aim to restore vision in the acute setting of CRAO.\n\nConsidering the patient's symptom onset within 3 hours, intra-arterial thrombolysis represents the intervention with the strongest evidence base for achieving visual recovery in acute CRAO.\n\nThe final answer is $\\boxed{D}$."}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-008", "question": "A 34-year-old professional baseball pitcher presents with progressive shoulder pain and weakness during the late cocking phase of throwing. MRI reveals a partial articular-sided supraspinatus tear with a posterosuperior labral tear. Physical examination demonstrates 145 degrees of external rotation and only 25 degrees of internal rotation in 90 degrees of abduction. The total arc of motion is preserved compared to the contralateral side. Which biomechanical adaptation is the PRIMARY contributor to this pathology?", "options": ["Anterior capsular laxity with increased humeral head translation", "Posterior capsular contracture with posterosuperior humeral head migration", "Scapular dyskinesis with altered glenohumeral kinematics", "Rotator cuff fatigue with dynamic superior humeral head migration", "Biceps tendon subluxation with altered force coupling"], "answer": "B", "answer_index": 1, "explanation": "This presentation describes glenohumeral internal rotation deficit (GIRD) with internal impingement syndrome. Posterior capsular contracture shifts the glenohumeral contact point posterosuperiorly during abduction and external rotation, causing the greater tuberosity to impinge on the posterosuperior labrum and articular surface of the rotator cuff. While anterior laxity and scapular dyskinesis may contribute, the primary biomechanical driver is posterior capsular tightness causing the characteristic GIRD pattern with preserved total arc of motion.", "generator_model": "claude-opus-4-5-20251101", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "abms_specialty": "Orthopedic Surgery", "abms_source": "target_topic", "source_label_raw": "Orthopedic Surgery", "source_quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed129-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251218T014545383Z_claude-opus-4-5-20251101_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251218T014545383Z_claude-opus-4-5-20251101_seed129.jsonl", "pred": "B", "model_outputs": "The patient is a professional baseball pitcher, an overhead athlete who engages in repetitive throwing. The symptoms of progressive shoulder pain and weakness during the late cocking phase (maximum external rotation and abduction) are characteristic of pathologies arising from the stresses of this phase.\n\nThe MRI findings of a partial articular-sided supraspinatus tear and a posterosuperior labral tear are common in overhead athletes. The physical examination reveals significantly limited internal rotation (25 degrees) and increased external rotation (145 degrees), a pattern known as Glenohumeral Internal Rotation Deficit (GIRD). While the total arc of motion is preserved, this altered distribution of motion is a key biomechanical adaptation in throwers.\n\nLet's analyze the options:\n\nA. Anterior capsular laxity with increased humeral head translation: While anterior laxity can occur, GIRD (limited IR, increased ER) is more directly linked to posterior capsular issues. Increased translation is a general sign of instability, and the specific findings suggest a more localized problem related to impingement in a loaded position.\n\nB. Posterior capsular contracture with posterosuperior humeral head migration: A tight posterior capsule limits internal rotation. To achieve sufficient external rotation for throwing, the athlete compensates by gaining excessive ER. In the late cocking phase, this contracted capsule can cause the humeral head to translate superiorly and posteriorly, leading to internal impingement. This impingement occurs between the posterior-superior rim of the glenoid and the humeral head, pinching the posterosuperior labrum and the articular side of the supraspinatus and infraspinatus tendons, which directly explains the MRI findings and the location of pain during the late cocking phase. This option provides a cohesive explanation for GIRD, the specific tears, and the symptomatic phase.\n\nC. Scapular dyskinesis with altered glenohumeral kinematics: Scapular dyskinesis is a common contributing factor to shoulder pathology in overhead athletes. It can lead to altered glenohumeral mechanics and contribute to impingement and instability. However, while dyskinesis influences overall glenohumeral kinematics, the specific pattern of GIRD and the resulting internal impingement mechanism described in option B is often considered the primary driver of *these particular* findings (posterosuperior labral tear, articular supraspinatus tear, and pain in late cocking). Dyskinesis is often a consequence or co-factor, but posterior capsular contracture leading to GIRD and subsequent humeral head migration is a more direct and primary biomechanical adaptation for this specific presentation.\n\nD. Rotator cuff fatigue with dynamic superior humeral head migration: Rotator cuff fatigue is prevalent in overhead athletes and can lead to pain and reduced performance. Fatigue can contribute to dynamic superior migration if the dynamic stabilizers fail. However, fatigue is more of a consequence of chronic overload or a contributor to instability rather than the primary biomechanical *adaptation* that leads to GIRD and the observed tears.\n\nE. Biceps tendon subluxation with altered force coupling: Biceps tendon issues can cause anterior shoulder pain, but they are not the primary explanation for posterior capsular contracture, GIRD, or posterosuperior labral tears, which are associated with internal impingement.\n\nConsidering the profound GIRD, the location of the labral and rotator cuff tears in the posterosuperior aspect, and the pain occurring during the late cocking phase, posterior capsular contracture leading to internal impingement and subsequent humeral head migration is the most fitting primary biomechanical adaptation.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-009", "question": "A 72-year-old man is admitted to the ICU with septic shock from pneumonia. Despite adequate fluid resuscitation and norepinephrine at 0.5 mcg/kg/min, MAP remains 58 mmHg. Echocardiography shows hyperdynamic left ventricle with EF 75%, small LV cavity, and IVC diameter of 0.8 cm with >50% respiratory variation. Lactate is 6.2 mmol/L. Which vasopressor strategy is most appropriate?", "options": ["Add vasopressin 0.03 units/min", "Add epinephrine infusion", "Add phenylephrine infusion", "Add angiotensin II infusion", "Increase norepinephrine to maximum dose before adding second agent"], "answer": "A", "answer_index": 0, "explanation": "Current sepsis guidelines recommend adding vasopressin (up to 0.03 units/min) as the second-line vasopressor when norepinephrine fails to achieve target MAP, typically when norepinephrine exceeds 0.25-0.5 mcg/kg/min. Vasopressin acts via V1 receptors independent of catecholamine pathways, which may be downregulated in sepsis. The VASST trial showed potential mortality benefit in less severe septic shock. The echocardiographic findings suggest adequate volume status (small IVC with variation indicates fluid responsiveness is exhausted). Angiotensin II is reserved for refractory vasodilatory shock after multiple agents. Phenylephrine may reduce cardiac output.", "generator_model": "claude-opus-4-5-20251101", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Critical Care Medicine", "abms_specialty": "Critical Care Medicine", "abms_source": "topics_mapped", "source_label_raw": "critical care", "source_quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed126", "source_question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed126-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251129T135352000Z_claude-opus-4-5-20251101_seed126", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251129T135352000Z_claude-opus-4-5-20251101_seed126.jsonl", "pred": "A", "model_outputs": "The patient is in septic shock, evidenced by hypotension (MAP 58 mmHg) despite adequate fluid resuscitation and requiring norepinephrine. The echocardiographic findings of a hyperdynamic left ventricle with a reduced LV cavity size and absent or minimal IVC distension with significant respiratory variation strongly suggest a state of low systemic vascular resistance (SVR) typical of distributive shock. The elevated lactate (6.2 mmol/L) confirms tissue hypoperfusion.\n\nThe patient is already receiving norepinephrine, a first-line vasopressor for septic shock. His MAP is below the target of 65 mmHg, and he is on a moderate dose of norepinephrine (0.5 mcg/kg/min). The question asks for the most appropriate vasopressor strategy to increase MAP.\n\nLet's evaluate the options:\n\nA. Add vasopressin 0.03 units/min: Vasopressin is a second-line agent often added to norepinephrine in septic shock when the target MAP is not achieved. It acts via V1 receptors to cause vasoconstriction, independent of adrenergic receptors, and can help increase SVR without significantly increasing heart rate or myocardial contractility, which is beneficial in a patient with a hyperdynamic left ventricle. The Surviving Sepsis Campaign guidelines recommend adding vasopressin if MAP is not at goal despite initial norepinephrine therapy.\n\nB. Add epinephrine infusion: Epinephrine has both alpha-adrenergic (vasoconstrictor) and beta-adrenergic (inotropic and chronotropic) effects. While it can increase MAP, its positive chronotropic and inotropic effects might exacerbate myocardial oxygen demand in certain patients, and it's generally not the preferred second agent in septic shock when norepinephrine is failing, especially if the heart is already hyperdynamic.\n\nC. Add phenylephrine infusion: Phenylephrine is a pure alpha-adrenergic agonist that increases SVR. However, it can reduce cardiac output by increasing afterload on the left ventricle and potentially decreasing stroke volume, which could be detrimental in a patient with already low SVR and a hyperdynamic LV.\n\nD. Add angiotensin II infusion: Angiotensin II is a potent vasoconstrictor approved for use in septic shock refractory to other vasopressors. It is generally considered a third-line agent when other therapies have failed.\n\nE. Increase norepinephrine to maximum dose before adding second agent: While norepinephrine can be titrated to higher doses, there isn't a strict universally defined \"maximum dose\" before adding a second agent. Pushing norepinephrine to very high doses can be associated with increased risks of arrhythmias, visceral ischemia, and mortality. Guidelines typically suggest adding a second agent like vasopressin if MAP is not achieved with a reasonable, but not necessarily maximum, dose of norepinephrine.\n\nConsidering the patient's clinical picture of septic shock with presumed low SVR and the fact that he is not at his MAP goal on norepinephrine, adding vasopressin is a well-supported and evidence-based strategy. It complements norepinephrine's action by providing non-adrenergic vasoconstriction.\n\nThe final answer is $\\boxed{A}$."}, {"quiz_id": "ABMS20260101_claude-opus-4-5-20251101_p01", "question_id": "ABMS20260101_claude-opus-4-5-20251101_p01-010", "question": "A 34-year-old man presents with progressive gait instability and cognitive decline over 18 months. Examination reveals vertical supranuclear gaze palsy, axial rigidity greater than limb rigidity, early postural instability with falls, and frontal release signs. Brain MRI shows midbrain atrophy with the 'hummingbird sign.' Genetic testing reveals a heterozygous mutation in the MAPT gene. His father died at age 45 with a similar presentation. Which tau isoform predominates in the neuropathological inclusions of this patient's condition?", "options": ["3-repeat tau (3R) exclusively", "4-repeat tau (4R) exclusively", "Mixed 3R and 4R tau in equal proportions", "Hyperphosphorylated tau without repeat domain specificity", "Truncated tau lacking the microtubule-binding domain"], "answer": "B", "answer_index": 1, "explanation": "This presentation describes progressive supranuclear palsy (PSP) phenotype associated with MAPT mutation. PSP is a 4-repeat (4R) tauopathy, with tau inclusions composed predominantly of 4R tau isoforms. Pick disease is characterized by 3R tau (A), while Alzheimer disease shows mixed 3R/4R tau (C). The tau in PSP is hyperphosphorylated but specifically 4R predominant, making (D) incomplete. Truncated tau (E) is not characteristic of PSP pathology.", "generator_model": "claude-opus-4-5-20251101", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "topics_mapped", "source_label_raw": "Neurology", "source_quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed123", "source_question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed123-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/claude-opus-4-5-20251101/20251129T135352000Z_claude-opus-4-5-20251101_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251129T135352000Z_claude-opus-4-5-20251101_seed123.jsonl", "pred": "B", "model_outputs": "The patient presents with progressive gait instability, cognitive decline, vertical supranuclear gaze palsy, axial rigidity, early postural instability with falls, and frontal release signs. The brain MRI shows midbrain atrophy with the 'hummingbird sign,' which is characteristic of Progressive Supranuclear Palsy (PSP). Genetic testing reveals a heterozygous mutation in the MAPT gene, which encodes tau protein, and a family history of a similar illness further supports a genetic tauopathy.\n\nProgressive Supranuclear Palsy (PSP) is a neurodegenerative disease characterized by the abnormal aggregation of tau protein in the brain. Neuropathologically, PSP is classified as a 4-repeat tauopathy, meaning the abnormal tau inclusions are composed predominantly, if not exclusively, of the 4-repeat (4R) tau isoforms. In contrast, Alzheimer's disease involves both 3-repeat (3R) and 4R tau isoforms, while Pick's disease is characterized by accumulations of 3R tau.\n\nTherefore, in the neuropathological inclusions of this patient's condition, which is strongly suggestive of PSP, 4-repeat tau (4R) predominates.\n\nLet's review the options:\nA. 3-repeat tau (3R) exclusively: This is typical of Pick's disease.\nB. 4-repeat tau (4R) exclusively: This is characteristic of PSP and other 4R tauopathies like Corticobasal Degeneration. Given the classic PSP signs, this is the most fitting.\nC. Mixed 3R and 4R tau in equal proportions: This is characteristic of Alzheimer's disease.\nD. Hyperphosphorylated tau without repeat domain specificity: While tau in PSP is hyperphosphorylated, this option does not address the isoform specificity, which is the key differentiating factor among tauopathies.\nE. Truncated tau lacking the microtubule-binding domain: Truncation can occur in various tauopathies, but the primary distinction sought here is likely the isoform composition.\n\nThe clinical presentation and MRI findings are highly suggestive of PSP, a 4R tauopathy. Thus, 4-repeat tau (4R) exclusively best describes the tau isoform predominance in the neuropathological inclusions of this patient's condition.\n\nThe final answer is $\\boxed{B}$."}]